IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Australia, U.K. Authorities Okay Ranbaxy’s Indian Plant

7:44 AM MDT | April 6, 2009 | Deepti Ramesh

Ranbaxy Laboratories (Gurgaon, India) says that the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA; London) and Australia’s drug regulatory body Therapeutic Goods Administration (Canberra) have issued GMP certificates for Ranbaxy’s Paonta Sahib, India facility, following a joint audit conducted last October. MHRA’s approval will cover U.K. product filings and also apply to product filings for the entire European Union, Ranbaxy says. The U.S. FDA said last month that the Paonta Sahib facility falsified data and test...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa